iPro2 Continuous Glucose Monitoring Device Receives FDA Approval

By Live Dr - Sat Nov 26, 8:49 am

MINNEAPOLIS – November 22, 2011 – Medtronic, Inc. (NYSE:MDT) today announced the Food and Drug Administration (FDA) approval of iPro®2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company. iPro2 simplifies Professional CGM and enables healthcare providers to obtain a more complete picture of glucose control for the patients they treat.  Professional CGM is used by healthcare providers to reveal low (hypoglycemia) and high (hyperglycemia) glucose excursions that can lead to the dangerous health complications of diabetes.  These excursions often go unnoticed with traditional A1C tests and standard glucose meter measurements.

“My vision is to make an iPro2 evaluation part of routine visits for many of my patients with diabetes. I find it particularly helpful in identifying repeated glucose lows at night and glucose highs after meals, issues that a near-normal A1C does not reveal,” said Dr. David Huffman of University Diabetes and Endocrine Consultants, a center that participated in a pre-market study for iPro2.  “I am one doctor in a busy office, but the advances with iPro2 will make Professional CGM accessible to more patients who need it.  I see that as better medicine.”

iPro2 provides healthcare providers insight into how diet, medication, and daily activities affect their patients’ glucose levels.  The system can be used to identify nocturnal hypoglycemia or hyperglycemia following meals, providing an opportunity to make therapy adjustments that can result in better glucose control.  Good glucose control can greatly reduce the risk of diabetes complications including blindness, kidney failure, amputation, impotence and heart disease.

AACE Supports Use of Professional CGM for Broad Range of Patients with Diabetes
The American Association of Clinical Endocrinologists (AACE) and the Endocrine Society, professional communities of physicians specializing in endocrinology, both recently published recommendations for use of Professional CGM on a broad range of patients with diabetes.  The AACE Consensus statement indicates that Professional CGM is ideal for type 1 or type 2 diabetes patients who are not achieving target A1C levels, and for patients who have recurrent hypoglycemia or hypoglycemia unawareness.  The statement also recommended Professional CGM for all pregnant women with type 1 diabetes and intermittent use in youth with type 1 diabetes. The Endocrine Society’s Clinical Guidelines suggested intermittent use in patients in whom clinicians worry about the dawn phenomenon, high glucose levels after meals, and in patients undergoing significant changes in their diabetes regimen.

“We are dedicated to bringing new innovations in continuous glucose monitoring to healthcare professionals and patients with the introduction of our fourth-generation Professional CGM, as well as ongoing sensor enhancements,” said Greg Meehan, Vice President and General Manager of the Continuous Glucose Monitoring business at Medtronic.  “CGM adoption is on the rise. We believe the combination of improved reimbursement for both clinicians and patients, increased clinical evidence as seen in the Medtronic STAR 3 and JDRF trials, as well as ongoing product advancements, are moving CGM devices toward the standard of care for diabetes management.”

How iPro2 Professional CGM Works
iPro2 is a three day evaluation and is designed to make CGM  easy for healthcare professionals and patients to use.  The setup procedure is now a simple three-step process enabled by a new all-in-one “Smart” Dock, which reduces the number of required components and eliminates the need for a computer.  Setup can be completed in a few minutes and includes inserting a glucose sensor into the patient’s skin, educating the patient, and connecting the iPro2 to the sensor.  The patient then conducts normal daily activities while the iPro2 records and stores as many as 288 glucose readings over each 24-hour period.

iPro2 is adaptable to almost any patient’s lifestyle because of its small, light and water-tight profile, and the patient is not required to interact with the device. After three days of wear, the patient returns iPro2 for upload to new web-based CareLink™ iPro software, which provides a summary of glucose data in easy-to-read reports.  Patient data and CareLink software can be accessed by any computer with an internet connection.  The new reports are also designed to be user-friendly and can be used as a teaching tool to motivate patients to implement changes in their diabetes management by seeing the effects that food, exercise, stress, medications, or other activities have on glucose levels.

More information on iPro2 is available for healthcare providers at (www.medtronicdiabetes.com/iPro2) and for patients at (www.medtronicdiabetes.com/iProEvaluation).

About CGM Systems
A Professional CGM system, such as iPro2, is a clinician-owned device that collects glucose data without patient interaction for retrospective review.  A Personal CGM system is a patient-owned device that displays real-time glucose data; it is available in a standalone CGM device – the Guardian® REAL-Time System – or as part of the Medtronic integrated insulin system, the MiniMed Paradigm® REAL-Time Revel™ System, which combines CGM with insulin pump therapy.

About the Diabetes Business at Medtronic
The Diabetes business at Medtronic (www.medtronicdiabetes.com) is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software, as well as world-class, 24/7 expert consumer and professional service and support.

About Medtronic
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.


Comments -49 - 0 of 37First« PrevNext »Last
  1. Hello. impressive job. I did not anticipate this. https://php665.com/

  2. of writing i am as well delighted to share my know-how here with colleagues. https://bzp65.com/

  3. Awesome! Its in fact amazing paragraph, I have got much clear idea regarding from this piece of https://bzp65.com/

  4. This is a impressive story. Thanks! https://bzp65.com/

  5. Awesome! Its in fact amazing paragraph, I have got much clear idea regarding from this piece of https://bzp65.com/

  6. It?s hard to come by knowledgeable people on this subject, however, you https://bzp65.com/

  7. Don’t wear seat belts lest you drown in you own urine? https://php665.com/

  8. I like the helpful info you provide in your articles. I will bookmark your weblog and check again here regularly. https://php665.com/

  9. here! Good luck for the next! https://php665.com/

  10. here! Good luck for the next! https://php665.com/

  11. What’s up, after reading this awesome piece https://php665.com/

  12. This is a impressive story. Thanks! https://php665.com/

  13. ouse, by a remarkably noteworthy rendering of the immortal Thomas Osborne Davis’ evergreen verses (happily too familiar to need recalling here) A nation once again in the execution of which the veteran patriot champion may be said without fear of contradiction to have fairly excelled himself. The Irish Caruso-GaribaldiPlease visit my webpage : 인터넷카지노 https://bxx100.com

  14. at a time to show her understandings. Handed down from father to, mother to daughter, I mean. Bred in the bone. Milly for example drying her handkerchief on the mirror to save the ironing. Best place for an ad to catch a woman’s eye on a mirror. And when I sent her for Molly’s Paisley shawl to Prescott’s by the way thaAlso visit my site : 바카라사이트 https://gam77.xyz/바카라사이트

  15. ld look at him all day long curly head and his shoulders his finger up for you to listen theres real beauty and poetry for you I often felt I wanted to kiss him all over also his lovely young cock there so simple I wouldnt mind taking him in my mouth if nobody was looking as if it was asking you to suck it so clean andAlso visit my webpage : 삼삼카지노 https://bxx100.com

  16. es, their greatest doctors, the O’Shiels, the O’Hickeys, the O’Lees, have sedulously set down the divers methods by which the sick and the relapsed found again health whether the malady had been the trembling withering or loose boyconnell flux. Certainly in every public work which in it anything of gravity contains prePlease visit my website : 바카라사이트 https://bxx100.com

  17. to be. Wisdom while you wait. In Gerard’s rosery of Fetter lane he walks, greyedauburn. One life is all. One body. Do. But do. Done anyhow. Postal order, stamp. Postoffice lower down. Walk now. Enough. Barney Kiernan’s I promised to meet them. Dislike that job. House of mourning. Walk. Pat! Doesn’t hear. DPlease visit my website : 우리카지노 https://gam77.xyz

  18. now, councillor, the Manx parliament. Innuendo of home rule. Tourists, you know, from the isle of Man. Catches the eye, you see. Can you do that? I could ask him perhaps about how to pronounce that voglio. But then if he didn’t know only make it awkward for him. Better not. We can do that, the foreman said. HavAlso visit my webpage : 슬롯 https://bxx100.com

  19. The wand in Lynch’s hand flashes: a brass poker. Stephen stands at the pianola on which sprawl his hat and ashplant. With two fingers he repeats once more the series of empty fifths. Florry Talbot, a blond feeble goosefat whore in a tatterdemalion gown of mildewed strawberry, lolls spreadeagle in the sofacorner, her liPlease visit my website : 온라인바카라 https://bxx100.com

  20. Black on black in the Charger I’m creepin’ Rub me the right way, you might get a genie B.o.B, black Houdini

  21. of writing i am as well delighted to share my know-how here with colleagues. https://newone2017.com/

  22. With thanks! Valuable information!

  23. Good attorney at law facts. Congratulations to you personally regarding writing this vlogger terfavorit. I’m going to can come here again for additional. Just about any exposure to a dwi Attorney at law?

  24. With thanks! Valuable information! https://newone2017.com/

  25. With thanks! Valuable information!

  26. Black on black in the Charger I’m creepin’ Rub me the right way, you might get a genie B.o.B, black Houdini

  27. Hello. impressive job. I did not anticipate this. https://newone2017.com/

  28. With thanks! Valuable information!

  29. I got what you mean,saved to fav, very decent site. https://newone2017.com/

  30. With thanks! Valuable information!

  31. here! Good luck for the next! https://newone2017.com/

  32. Don’t wear seat belts lest you drown in you own urine?

  33. Your blog on iPro2 Continuous Glucose Monitoring Device Receives FDA Approval – LiveDr Admissions is very good. We hope you can continue delivering many lot post soon. Long live livedr.org

  34. I conceive this web site has got some real good information for everyone https://newone2017.com/

  35. With thanks! Valuable information!

  36. Amaze, great blog page design . jual pneumatic conveyor indonesiaand style! Exactly how extended are you blogs intended for? you’ve made writing a blog glimpse quick. The complete peek of this website is excellent, plus the articles!

  37. It’s a nice and practical part of details. I’m pleased you embraced this handy details with us. Be sure to keep us advised in this way. Many thanks for spreading.. brand endorsement

Comments -49 - 0 of 37First« PrevNext »Last

Leave a Reply